|
HHS- Office of the Assistant Secretary for Preparedness and Response (ASPR)
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NCI, NIAID
|
NCI and NIAID participate in ASPR''s chemical, biological, radiological and nuclear defense team and Senior Medical Advisor to ASPR
|
|
HHS/USAID/OMB Zika Coordination Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NICHD, NIAID, NIEHS
|
This is a collaborative effort by the Department of Health and Human Services, the United States Agency for International Development, and office of Management and Budget to address issues regarding Zika virus. The goal of this group is to develop a coordinated US government strategy.
|
|
HIV/AIDS Cancer Match Study
|
Research Initiative
|
CDC
|
NCI
|
Investigators use data from the NCI HIV/AIDS Cancer Match Study, in conjunction with data from the CDC HIV surveillance program, to estimate the burden of cancer in HIV-infected people in the United States.
|
|
HOPE Act Research Criteria Workshop
|
Meeting/ Workshop
|
CDC, CMS, FDA
|
NIAID, NIDDK
|
The goal of this workshop was to educate the transplant community about implementation of the Final Human Immunodeficiency Virus (HIV) Organ Policy Equity (HOPE) Act Safeguards and Research Criteria for Transplantation of Organs Infected With HIV, published in the Federal Register on 11/25/2015.
|
|
HPV Working Group for the Advisory Committee on Immunization Practices (ACIP)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NCI
|
HPV Working Group for the Advisory Committee on Immunization Practices ACIP Work Groups (WGs) serve in a key scientific role in support of vaccine policy development by the ACIP. ACIP WGs conduct extensive background reviews of relevant research data to develop options for recommendations for use of vaccines in the civilian population of the United States. WGs are convened solely to gather scientific information related to vaccines and the diseases they prevent, to analyze relevant issues and data, and to draft policies or options for review, deliberation and vote by the ACIP.
|
|
HRSA Interagency Committee On Emergency Medical Services For Children Research
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD, NIGMS
|
This committee supports improving emergency medical services for child research.
|
|
HRSA/NIH Joint Technical Expert Consultation on Trauma and HIV Care
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA, SAMHSA
|
NIMH, NIAID, NIDA
|
The Health Resources and Services Administration (HRSA) and the National Institutes of Health (NIH) held a one-day meeting with experts on trauma treatment and research to review the evidence for implementing care practices that address trauma in HRSA’s Ryan White HIV/AIDS Program (RWHAP). HRSA and NIH led the meeting, which included representatives from the White House Office on National AIDS Policy, National Institute of Mental Health (NIMH), National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), Substance Abuse and Mental Health Services Administration (SAMHSA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), Kaiser Permanente, and academic experts.
|
|
Human Immunology Project Consortium Collaboration on Mechanism Studies of Influenza Vaccination
|
Research Initiative
|
FDA
|
NIAID
|
The NIAID-funded Human Immunology Project Consortium (HIPC) supports an Infrastructure/Opportunity Fund to create a shared research infrastructure for ongoing development of the immune profiling network, support collaborative projects, pilot projects, and new research opportunities for the HIPC investigators.
|
|
I-Corps @ NIH
|
Training Initiative
|
CDC
|
NCI, NCATS, NCCIH, NHGRI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINDS
|
The I-Corps™ at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. The program is designed to provide three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps™ teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies.
|
|
ICARE: Interagency Collaborative to Advance Research in Epilepsy
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS
|
NINDS, FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH
|
The Interagency Collaborative to Advance Research in Epilepsy (ICARE) is an interagency epilepsy working group that includes broad representation across the NIH ICs involved in epilepsy-related research, as well as across HHS and other Federal agencies and multiple epilepsy research and patient advocacy groups with a primary focus on biomedical research. The purpose of this group, which is led by the National Institute of Neurological Disorders and Stroke, is to increase communication among institutes and agencies sponsoring epilepsy-related research and explore opportunities for increased coordination. The group’s annual meetings provide a forum for sharing information about ongoing and planned epilepsy research activities, highlighting advances, discussing needs and opportunities, and promoting increased collaboration toward common research goals.
|